Evidence map›Paper›PMID 36651261›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[Ultrasound combined with Ki67 detection for analyzing contributing factors of failure to cure and recurrence of hyperthyroidism in patients with Graves disease after

Y Wang, L Hong, G Lü, S Yang, L Li, X Huang, H Shen

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Y WangThird Clinical Medical College, Fujian Medical University, Fuzhou 350000, China.
L HongDepartment of Nuclear Medicine, Zhangzhou Hospital Affiliated to Fujian Medical University, Zhangzhou 363005, China.
G LüQuanzhou Medical College, Quanzhou 362000, China.
S YangDepartment of Ultrasound, Zhangzhou Hospital Affiliated to Fujian Medical University, Zhangzhou 363005, China.
L LiDepartment of Ultrasound, Zhangzhou Hospital Affiliated to Fujian Medical University, Zhangzhou 363005, China.
X HuangDepartment of Nuclear Medicine, Zhangzhou Hospital Affiliated to Fujian Medical University, Zhangzhou 363005, China.
H ShenDepartment of Ultrasound, Zhangzhou Hospital Affiliated to Fujian Medical University, Zhangzhou 363005, China.
Fujian Medical University · CNQuanzhou Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze factors associated with failure to cure or recurrence of hyperthyroidism in patients with Graves disease (GD) after

methodsEighty-nine patients with GD receiving

resultsAmong the 89 patients, 27 patients were found to have failure to cure or recurrence of hyperthyroidism, 50 had premature hypothyroidism, 1 patient had euthyroidism, and 11 patients were lost to follow-up at the end of the 1-year follow-up. Analysis of the competitive risk model showed that status of Ki67 expression,

conclusionIn patients with GD, the expression of Ki67 in thyroid follicular epithelial cells,

Indexed as

Graves DiseaseHyperthyroidismHypothyroidismAntithyroid AgentsHumansIodine RadioisotopesKi-67 AntigenRecurrenceTreatment OutcomeAntithyroid AgentsIodine-131Iodine RadioisotopesKi-67 AntigenMKI67 protein, human131I treatmentcompeting risk modelGraves diseaseKi67

Identifiers

PMID36651261
PMCPMC9878411
OpenAlexW4317360756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.